| 1. J M Hernández,J Llosá,A Martínez. (1991-08-01) [Antifungal activity of nitroxoline].. Enfermedades infecciosas y microbiologia clinica, 9 ((7)): (439-440). [PMID:1799618] |
| 2. J M Hernández Molina,J Llosá,A Ventosa. (1991-07-01) In vitro activity of nitroxoline against clinical isolates of Candida species.. Mycoses, 34 ((7-8)): (323-325). [PMID:1803236] |
| 3. P Bourlioux,D Karam,A Amgar,M Perdiz. (1989-06-01) [Relation of the chelating property of nitroxoline, the surface hydrophobicity and the inhibition of bacterial adherence].. Pathologie-biologie, 37 ((5 Pt 2)): (600-604). [PMID:2571967] |
| 4. V K Shormanov,O N Zarudnaia. (1994-07-01) [The characteristics of extracting 2-acetylamino-5-nitrothiazole and 5-nitro-8-hydroxyquinoline from aqueous solutions].. Sudebno-meditsinskaia ekspertiza, 37 ((3)): (26-28). [PMID:7974608] |
| 5. V E Rodoman,V P Avdoshin,M I Andriukhin. (1998-02-14) [Disorders of kidney function in patients with benign prostatic hyperplasia].. Urologiia i nefrologiia, ((6)): (24-26). [PMID:9461783] |
| 6. H Latrache,P Bourlioux,M Karroua,H Zahir,A Hakkou. (2001-08-15) Effects of subinhibitory concentrations of nitroxoline on the surface properties of Escherichia coli.. Folia microbiologica, 45 ((6)): (485-490). [PMID:11501411] |
| 7. A V Yatsenko,K A Paseshnichenko,V V Chernyshev,H Schenk. (2002-01-10) Powder diffraction study of the hydrogen bonds in nitroxoline and its hydrochloride.. Acta crystallographica. Section C, Crystal structure communications, 58 ((Pt 1)): (o19-o21). [PMID:11781483] |
| 8. F Rodor,M Castelain,N Prost,M C Galland,N Nguyen,R Benjelloun,M Valli,M J Jean-Pastor. (2002-08-21) [Is nitroxoline an allergen?].. Therapie, 57 ((2)): (204-205). [PMID:12185975] |
| 9. A Amgar,C Bonissol,B Stoiljkovic. (1989-07-01) Activity in vitro of urine samples from patients treated by nitroxoline against mycoplasmas.. Journal of chemotherapy (Florence, Italy), 1 ((4 Suppl)): (226-228). [PMID:16312380] |
| 10. Mohamed M Ghoneim,Hanaa S El-Desoky,Mohamed M Abdel-Galeil. (2010-09-14) Electrochemistry of the antibacterial and antifungal drug nitroxoline and its determination in bulk form, pharmaceutical formulation and human blood.. Bioelectrochemistry (Amsterdam, Netherlands), 80 ((2)): (162-168). [PMID:20833114] |
| 11. Joong Sup Shim,Yoshiyuki Matsui,Shridhar Bhat,Benjamin A Nacev,Jing Xu,Hyo-eun C Bhang,Surajit Dhara,Kee Chung Han,Curtis R Chong,Martin G Pomper,Alan So,Jun O Liu. (2010-11-20) Effect of nitroxoline on angiogenesis and growth of human bladder cancer.. Journal of the National Cancer Institute, 102 ((24)): (1855-1873). [PMID:21088277] |
| 12. Bojana Mirković,Miha Renko,Samo Turk,Izidor Sosič,Zala Jevnikar,Nataša Obermajer,Dušan Turk,Stanislav Gobec,Janko Kos. (2011-05-21) Novel mechanism of cathepsin\u2005B inhibition by antibiotic nitroxoline and related compounds.. ChemMedChem, 6 ((8)): (1351-1356). [PMID:21598397] |
| 13. Hongchao Jiang,Jori E Taggart,Xiaoxi Zhang,Doris M Benbrook,Stuart E Lind,Wei-Qun Ding. (2011-09-09) Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline).. Cancer letters, 312 ((1)): (11-17). [PMID:21899946] |
| 14. Bojana Mirković,Izidor Sosič,Stanislav Gobec,Janko Kos. (2011-11-11) Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety.. PloS one, 6 ((11)): (e27197-e27197). [PMID:22073285] |
| 15. V Arjunan,P S Balamourougane,M Kalaivani,Arushma Raj,S Mohan. (2012-06-26) Experimental and theoretical quantum chemical investigations of 8-hydroxy-5-nitroquinoline.. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 96 (506-516). [PMID:22728969] |
| 16. A Sobke,M Klinger,B Hermann,S Sachse,S Nietzsche,O Makarewicz,P M Keller,W Pfister,E Straube. (2012-08-29) The urinary antibiotic 5-nitro-8-hydroxyquinoline (Nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc.. Antimicrobial agents and chemotherapy, 56 ((11)): (6021-6025). [PMID:22926564] |
| 17. Izidor Sosič,Bojana Mirković,Katharina Arenz,Bogdan Stefane,Janko Kos,Stanislav Gobec. (2012-12-21) Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.. Journal of medicinal chemistry, 56 ((2)): (521-533). [PMID:23252745] |
| 18. Serena Veschi,Laura De Lellis,Rosalba Florio,Paola Lanuti,Alberto Massucci,Nicola Tinari,Michele De Tursi,Pierluigi di Sebastiano,Marco Marchisio,Clara Natoli,Alessandro Cama. (2018-09-23) Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells.. Journal of experimental & clinical cancer research : CR, 37 ((1)): (236-236). [PMID:30241558] |
| 19. Rungrot Cherdtrakulkiat, Ratana Lawung, Sunanta Nabu, Srisurang Tantimavanich, Nujarin Sinthupoom, Supaluk Prachayasittikul, Virapong Prachayasittikul,. (2019-08-20) Nitroxoline: a potent antimicrobial agent against multidrug resistant Enterobacteriaceae.. EXCLI journal, ( 445-453 ). [PMID:31423123] |
| 20. Serena Veschi,Simone Carradori,Laura De Lellis,Rosalba Florio,Davide Brocco,Daniela Secci,Paolo Guglielmi,Mattia Spano,Anatoly P Sobolev,Alessandro Cama. (2020-06-27) Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents.. Journal of enzyme inhibition and medicinal chemistry, 35 ((1)): (1331-1344). [PMID:32588672] |
| 21. L Oliviero,M Perdiz,P Bourlioux. (1990-05-01) [Direct effect of nitroxoline in the inhibition of bacterial adherence to urinary catheters].. Pathologie-biologie, 38 ((5)): (455-458). [PMID:2195455] |
| 22. P Bourlioux,H Botto,D Karam,A Amgar,M Camey. (1989-05-01) [Inhibition of bacterial adherence by nitroxoline on cellular adhesion and on urinary catheter surfaces].. Pathologie-biologie, 37 ((5)): (451-454). [PMID:2674871] |
| 23. E Bergogne-Berezin,G Berthelot,C Muller-Serieys. (1987-06-01) [Present status of nitroxoline].. Pathologie-biologie, 35 ((5 Pt 2)): (873-878). [PMID:3309832] |
| 24. B V Soloveĭ,T P Soloveĭ. (1995-01-01) [Intensive combined therapy of patients with urogenital tuberculosis].. Problemy tuberkuleza, (1) ((1)): (30-32). [PMID:7761376] |
| 25. C Pelletier,P Prognon,P Bourlioux. (1995-03-01) Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains.. Antimicrobial agents and chemotherapy, 39 ((3)): (707-713). [PMID:7793877] |
| 26. C Pelletier,P Prognon,H Latrache,L Villart,P Bourlioux. (1994-05-01) [Microbiological consequences of chelation of bivalent metal cations by nitroxoline].. Pathologie-biologie, 42 ((5)): (406-411). [PMID:7824304] |
| 27. B Murugasu-Oei,T Dick. (2001-12-12) In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG.. International journal of antimicrobial agents, 18 ((6)): (579-582). [PMID:11738349] |
| 28. A I Sow,N Diop,C T Ndour,M Soumare,M Seydi,M F Cisse,A Samb. (2003-12-12) [Urinary tract infections in Dakar: etiologies, therapeutic basis].. Dakar medical, 45 ((1)): (59-61). [PMID:14666793] |
| 29. Gau-Yi Gao,Shan-Yang Lin. (2009-06-17) Thermodynamic investigations of nitroxoline sublimation by simultaneous DSC-FTIR method and isothermal TG analysis.. Journal of pharmaceutical sciences, 99 ((1)): (255-261). [PMID:19530075] |
| 30. Shridhar Bhat,Joong Sup Shim,Feiran Zhang,Curtis Robert Chong,Jun O Liu. (2012-03-07) Substituted oxines inhibit endothelial cell proliferation and angiogenesis.. Organic & biomolecular chemistry, 10 ((15)): (2979-2992). [PMID:22391578] |
| 31. Tomas Kudera,Ivo Doskocil,Hana Salmonova,Miloslav Petrtyl,Eva Skrivanova,Ladislav Kokoska. (2020-09-10) In Vitro Selective Growth-Inhibitory Activities of Phytochemicals, Synthetic Phytochemical Analogs, and Antibiotics against Diarrheagenic/Probiotic Bacteria and Cancer/Normal Intestinal Cells.. Pharmaceuticals (Basel, Switzerland), 13 ((9)): [PMID:32899218] |
| 32. Yi Sun, Junfeng Su, Amjad Ali, Tinglin Huang, Shuai Zhang, Yitian Min. (2023) Enhanced nitrate and cadmium removal performance at low carbon to nitrogen ratio through immobilized redox mediator granules and functional strains in a bioreactor. CHEMOSPHERE, 312 (137255). [PMID:36402354] |
I2405323